Haohai Life Sciences: Shareholders plan to reduce their shareholding by no more than 0.6432% of the company's shares.

Haohai Bioscience announced on the evening of June 24th that shareholder Lou Guoliang holds 3.69% of the company's shares and plans to reduce his holdings by a total of no more than 1.5 million shares through centralized bidding and block trading, accounting for no more than 0.6432% of the company's total share capital.